Interestingly, some clinical-pathological characteristics were mainly associated with radiomic features (tumor stage), and others (such as copy number alteration of CDK4 and PTEN2 and gene expression of BCL2 for ER —Estrogen receptor) performed better than radiomic features in predicting hormone receptor status (ER/PR). This evidence concerns the gene CDK4 and neoplasm.